Searched for
CLAVAM
Alkem Labs CEO Vikas Gupta may exit companyAlkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to de...- Obesity bet may drive focus on chronic segment: Alkem LabsAlkem Labs anticipates its upcoming semaglutide launch will drive a strategic shift from acute treatments to chronic care, including diabet...
- Pharma stocks: Time to change the prescription? 13 pharma stocks with an upside potential of up to 39%Close to three decades back, when Indian pharma firms began to move into the US market, they faced many challenges. And the fact is that th...
- Stock picks of the week: 5 stocks with consistent score improvement and return potential of more than 32% in 1 yearIn the long run, it is the bulls who always win. There is ample evidence to back this assertion. But, for the bulls to be successful in the...
- Paracetamol to PAN-D: CDSCO finds over 50 sub-standard drugs. Check full list of medicinesThe Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard quality'. The...
- Pharma companies seek more teeth for agencies to fight fakesIndia's leading drug makers, through the Indian Pharmaceutical Alliance, have petitioned the Supreme Court to enable police and drug inspec...
- Alkem Labs denies claims of Pan-D, Clavam 625 batches being not-of-standard qualityAlkem Laboratories has denied claims that its products Pan-D and Clavam 625 are of substandard quality. The company stated that an investig...
- CDSCO finds 50 common medicines substandard, including those for fever, blood pressure, diabetes, and acid refluxMore than 50 drugs for common conditions like high blood pressure, acid reflux, and erectile dysfunction have been found to be not-of-stand...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%Last Friday might be an exception but for the last few weeks, everything on the street appears good and green. When it happens, there is a ...
- These healthcare and pharma stocks may deliver more than 20% in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...
- Fundamental tailwinds are a stronger play than volatile markets? 5 Indian pharma stocks with upside potential of up to 31 %There is no doubt that the market is going through a volatile phase and bears are once again telling the street to never write them off. Wi...
- Fundamental tailwinds are a stronger play than volatile markets? 5 Indian pharma stocks with upside potential of up to 41%There is no doubt that the market is going through a volatile phase and bears are once again telling the street to never write them off. Wi...
- Tailwinds at the right time: 7 pharma stocks with an upside potential up to 37 %It is not very common to see tailwinds emerging for an industry at a time when it is ideal to own stocks from that space. But in the case o...
- After a long winter finally some tailwinds; 6 pharma stocks with upside potential of up to 31%While all pharma companies get classified into one sector they are very different at molecular level. Each company has its own operating ma...
- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
- Alkem Labs to grow chronic therapies, biosimilars to drive future growth: MDAlkem Laboratories, a top-seller of antibiotics, is focusing on the chronic therapy segments and is investing heavily in biosimilars and co...
- Alkem Labs to grow chronic therapies to drive future growth: MDThe Mumbai-based drug maker, which entered the US generics market over a decade ago, is also scaling back its investments in oral solids in...
- Covid & flu: Sales of respiratory, anti-infective drugs shoot up"We have seen a sharp rise in the sales of drugs like paracetamol, analgesics and drugs for respiratory illnesses," said Rajiv Singhal, gen...
- Paytm founder Vijay Shekhar Sharma youngest Indian billionaireOf the 2,208 billionaires in Forbes' 2018 list of the world's richest, just 63 are under the age of 40 and more than half (34) are self-mad...
- NPPA cuts antibiotic, stomach ulcer and abortion drug prices by 30%Indian drug pricing watchdog National Pharmaceutical Pricing Authority (NPPA) has cut prices of 24 more essential medicines.
Load More
